These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9062829)
1. Global and extended coagulation monitoring during extracorporeal lung assist with heparin-coated systems in ARDS patients. Gerlach M; Föhre B; Keh D; Riess H; Falke KJ; Gerlach H Int J Artif Organs; 1997 Jan; 20(1):29-36. PubMed ID: 9062829 [TBL] [Abstract][Full Text] [Related]
2. Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation. Urlesberger B; Zobel G; Rödl S; Dacar D; Friehs I; Leschnik B; Muntean W Int J Artif Organs; 1997 Dec; 20(12):708-12. PubMed ID: 9506788 [TBL] [Abstract][Full Text] [Related]
3. Comparison of a new heparin-coated dense membrane lung with nonheparin-coated dense membrane lung for prolonged extracorporeal lung assist in goats. Ichinose K; Okamoto T; Tanimoto H; Yoshitake A; Tashiro M; Sakanashi Y; Kuwana K; Tahara K; Kamiya M; Terasaki H Artif Organs; 2004 Nov; 28(11):993-1001. PubMed ID: 15504115 [TBL] [Abstract][Full Text] [Related]
4. A new heparin-bonded dense membrane lung combined with minimal systemic heparinization prolonged extracorporeal lung assist in goats. Okamoto T; Tashiro M; Sakanashi Y; Tanimoto H; Imaizumi T; Sugita M; Terasaki H Artif Organs; 1998 Oct; 22(10):864-72. PubMed ID: 9790085 [TBL] [Abstract][Full Text] [Related]
5. Heparin bonding of the extracorporeal circuit reduces thrombosis during prolonged lung assist in goats. Ao H; Tajiri A; Yanagi F; Okamoto T; Tashiro M; Sakanashi Y; Tanimoto H; Moon JK; Terasaki H ASAIO J; 2000; 46(6):723-9. PubMed ID: 11110270 [TBL] [Abstract][Full Text] [Related]
6. [Changes in platelets and blood coagulation during prolonged ECLA with a heparin bonded hollow fiber membrane lung]. Ezaki K Masui; 1990 Jul; 39(7):845-53. PubMed ID: 2214119 [TBL] [Abstract][Full Text] [Related]
7. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Mitusch R; Siemens HJ; Garbe M; Wagner T; Sheikhzadeh A; Diederich KW Thromb Haemost; 1996 Feb; 75(2):219-23. PubMed ID: 8815563 [TBL] [Abstract][Full Text] [Related]
8. Extracorporeal carbon dioxide removal performed with surface-heparinized equipment in patients with ARDS. Bindslev L; Böhm C; Jolin A; Hambraeus Jonzon K; Olsson P; Ryniak S Acta Anaesthesiol Scand Suppl; 1991; 95():125-30; discussion 130-1. PubMed ID: 1927222 [TBL] [Abstract][Full Text] [Related]
10. Experimental results using nafamostat mesilate as anticoagulant during extracorporeal lung assist for 24 hours in dogs. Okamoto T; Chung YK; Choi H; Terasaki H; Morioka T Artif Organs; 1993 Jan; 17(1):30-6. PubMed ID: 8422232 [TBL] [Abstract][Full Text] [Related]
11. Experimental evaluation of the V-point heparin-bonding system applied to a dense-membrane artificial lung during 24-hour extracorporeal circulation in beagles. Tashiro M; Okamoto T; Sakanashi Y; Ao H; Imaizumi T; Tanimoto H; Yanagi F; Sugita M; Mimura R; Terasaki H Artif Organs; 2001 Aug; 25(8):655-63. PubMed ID: 11531718 [TBL] [Abstract][Full Text] [Related]
12. Platelet involvement in the activated coagulation time of heparinized blood. Moorehead MT; Westengard JC; Bull BS Anesth Analg; 1984 Apr; 63(4):394-8. PubMed ID: 6367544 [TBL] [Abstract][Full Text] [Related]
13. Factors Affecting the Discrepancy Between Coagulation Times on Extracorporeal Circulation Using Unfractionated Heparin in Children and Young Adults. Haga T; Misaki Y; Sakaguchi T; Akamine Y Clin Appl Thromb Hemost; 2024; 30():10760296241252838. PubMed ID: 38711321 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal lung assist for sepsis and acute respiratory distress syndrome. Iwashita Y; Imai H Cardiovasc Hematol Disord Drug Targets; 2015; 15(1):46-56. PubMed ID: 25567336 [TBL] [Abstract][Full Text] [Related]
16. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders]. Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207 [TBL] [Abstract][Full Text] [Related]
17. Does continuous heparinization influence platelet function in the intensive care patient? Boldt J; Müller M; Rothe A; Lenzen P; Hempelmann G Intensive Care Med; 1997 May; 23(5):567-73. PubMed ID: 9201530 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients. Atallah S; Liebl M; Fitousis K; Bostan F; Masud F Perfusion; 2014 Sep; 29(5):456-61. PubMed ID: 24570077 [TBL] [Abstract][Full Text] [Related]
19. Intersubject variability in the anticoagulant response to heparin in vitro. Bjornsson TD; Wolfram KM Eur J Clin Pharmacol; 1982; 21(6):491-7. PubMed ID: 6176454 [TBL] [Abstract][Full Text] [Related]
20. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo. Eichinger S; Wolz M; Nieszpaur-Los M; Schneider B; Lechner K; Eichler HG; Kyrle PA Thromb Haemost; 1994 Dec; 72(6):831-5. PubMed ID: 7740450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]